They are prescribed off-label by clinicians based on clinical judgment, existing research, and patient-specific factors
He is Co-Chief Investigator for the PROHIBIT-ICH trial
However, these synthetic versions are engineered to resist breakdown by the DPP-4 enzyme that rapidly degrades natural GLP-1, remain active in the bloodstream for much longer periods (days to weeks versus minutes for natural GLP-1), and achieve blood concentrations far higher than the body naturally produces
This can illuminate better management and treatment methods in terms of avoiding depression in GD patients and treating patients with depressive complications
Handy DE, Lubos E, Yang Y, Galbraith JD, Kelly N, Zhang Y-Y, et al
Tirzepatide has shown even greater potential